A Randomised Phase II Feasibility Study of Docetaxel plus Prednisolone vs Docetaxel plus Prednisolone plus Zoledronic acid vs docetaxel plus Prednisolone plus Strontium-89 vs Docetaxel plus prednisolone plus Zoledronic acid plus Strontium-8

Medicine & Life Sciences

1. Strontium-89 100%
2. Zoledronic Acid 75%
3. Cost-Benefit Analysis 49%
4. Prostatic Neoplasms 45%
5. Quality-Adjusted Life Years 45%
6. Costs and Cost Analysis 35%
7. Bone and Bones 34%
8. Drug Therapy 33%
9. Therapeutics 9%
10. Cost Savings 9%
11. Docetaxel 9%
12. National Health Programs 8%
13. Health Expenditures 8%
14. Health Status 7%
15. Primary Health Care 6%
16. Quality of Life 5%